Meaghan L O'Donnell1, Nathan Alkemade1, Angela Nickerson1, Mark Creamer1, Alexander C McFarlane1, Derrick Silove1, Richard A Bryant1, David Forbes1. 1. Meaghan L. O'Donnell, PhD, Nathan Alkemade, PhD, Australian Centre for Posttraumatic Mental Health, Carlton, Victoria and Department of Psychiatry, University of Melbourne, Parkville, Victoria; Angela Nickerson, PhD, School of Psychology University of New South Wales, Sydney, New South Wales; Mark Creamer, PhD, Department of Psychiatry, University of Melbourne, Parkville, Victoria; Alexander C. McFarlane, AO, MD, FRANZCP, Centre for Traumatic Stress, University of Adelaide, Adelaide, South Australia; Derrick Silove, MD, FRANZCP, Department of Psychiatry University of New South Wales, Sydney and Mental Health Centre, Psychiatry Research and Teaching Unit, Liverpool, New South Wales; Richard A. Bryant, PhD, School of Psychology, University of New South Wales, Sydney, New South Wales; David Forbes, PhD, Australian Centre for Posttraumatic Mental Health, Carlton, Victoria and Department of Psychiatry, University of Melbourne, Parkville, Victoria, Australia.
Abstract
BACKGROUND: There have been changes to the criteria for diagnosing post-traumatic stress disorder (PTSD) in DSM-5 and changes are proposed for ICD-11. AIMS: To investigate the impact of the changes to diagnostic criteria for PTSD in DSM-5 and the proposed changes in ICD-11 using a large multisite trauma-exposed sample and structured clinical interviews. METHOD: Randomly selected injury patients admitted to four hospitals were assessed 72 months post trauma (n = 510). Structured clinical interviews for PTSD and major depressive episode, as well as self-report measures of disability and quality of life were administered. RESULTS: Current prevalence of PTSD under DSM-5 scoring was not significantly different from DSM-IV (6.7% v. 5.9%, z = 0.53, P = 0.59). However, the ICD-11 prevalence was significantly lower than ICD-10 (3.3% v. 9.0%, z = -3.8, P<0.001). The PTSD current prevalence was significantly higher for DSM-5 than ICD-11 (6.7% v. 3.3%, z = 2.5, P = 0.01). Using ICD-11 tended to show lower rates of comorbidity with depression and a slightly lower association with disability. CONCLUSIONS: The diagnostic systems performed in different ways in terms of current prevalence rates and levels of comorbidity with depression, but on other broad key indicators they were relatively similar. There was overlap between those with PTSD diagnosed by ICD-11 and DSM-5 but a substantial portion met one but not the other set of criteria. This represents a challenge for research because the phenotype that is studied may be markedly different according to the diagnostic system used. Royal College of Psychiatrists.
BACKGROUND: There have been changes to the criteria for diagnosing post-traumatic stress disorder (PTSD) in DSM-5 and changes are proposed for ICD-11. AIMS: To investigate the impact of the changes to diagnostic criteria for PTSD in DSM-5 and the proposed changes in ICD-11 using a large multisite trauma-exposed sample and structured clinical interviews. METHOD: Randomly selected injurypatients admitted to four hospitals were assessed 72 months post trauma (n = 510). Structured clinical interviews for PTSD and major depressive episode, as well as self-report measures of disability and quality of life were administered. RESULTS: Current prevalence of PTSD under DSM-5 scoring was not significantly different from DSM-IV (6.7% v. 5.9%, z = 0.53, P = 0.59). However, the ICD-11 prevalence was significantly lower than ICD-10 (3.3% v. 9.0%, z = -3.8, P<0.001). The PTSD current prevalence was significantly higher for DSM-5 than ICD-11 (6.7% v. 3.3%, z = 2.5, P = 0.01). Using ICD-11 tended to show lower rates of comorbidity with depression and a slightly lower association with disability. CONCLUSIONS: The diagnostic systems performed in different ways in terms of current prevalence rates and levels of comorbidity with depression, but on other broad key indicators they were relatively similar. There was overlap between those with PTSD diagnosed by ICD-11 and DSM-5 but a substantial portion met one but not the other set of criteria. This represents a challenge for research because the phenotype that is studied may be markedly different according to the diagnostic system used. Royal College of Psychiatrists.
Authors: Anthony J Rosellini; Murray B Stein; Lisa J Colpe; Steven G Heeringa; Maria V Petukhova; Nancy A Sampson; Michael Schoenbaum; Robert J Ursano; Ronald C Kessler Journal: Depress Anxiety Date: 2015-04-04 Impact factor: 6.505
Authors: Amit Lazarov; Benjamin Suarez-Jimenez; Ofir Levi; Daniel D L Coppersmith; Gadi Lubin; Daniel S Pine; Yair Bar-Haim; Rany Abend; Yuval Neria Journal: Psychol Med Date: 2019-08-27 Impact factor: 7.723
Authors: Blair E Wisco; Mark W Miller; Erika J Wolf; Dean Kilpatrick; Heidi S Resnick; Christal L Badour; Brian P Marx; Terence M Keane; Raymond C Rosen; Matthew J Friedman Journal: Psychiatry Res Date: 2016-04-16 Impact factor: 3.222
Authors: Anna C Barbano; Willem F van der Mei; Terri A deRoon-Cassini; Ettie Grauer; Sarah Ryan Lowe; Yutaka J Matsuoka; Meaghan O'Donnell; Miranda Olff; Wei Qi; Andrew Ratanatharathorn; Ulrich Schnyder; Soraya Seedat; Ronald C Kessler; Karestan C Koenen; Arieh Y Shalev Journal: Depress Anxiety Date: 2019-01-25 Impact factor: 6.505